Compounds > amikacin

Page last updated: 2024-08-23

amikacin and Bronchiectasis

amikacin has been researched along with Bronchiectasis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	2 (28.57)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (42.86)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Abelleira, R; Casal, A; Riveiro, V; Valdés, L	1
Rajagopala, S	1
Bhattacharyya, D; Brewer, CC; Fleshner, M; Folio, LR; Glaser, TS; Holland, SM; Olivier, KN; Park, IK; Prevots, DR; Sampaio, EP; Shallom, S; Shaw, PA; Siegelman, JR; Zalewski, CK; Zelazny, AM	1
Atassi, K; Bassinet, L; Honoré, I; Housset, B; Jabot, L; Maître, B; Mangiapan, G; Monnet, I; Schubel, K	1
Cremades, MJ; Gobernado, M; Menéndez, R; Santos, M	1
Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A	1
Bataillon, V; Lafitte, JJ; Lhermitte, M; Pommery, J; Roussel, P	1

Reviews

1 review(s) available for amikacin and Bronchiectasis

Article	Year
Advances in inhaled antibiotics for management of respiratory tract infections. Current opinion in pulmonary medicine, 2023, 05-01, Volume: 29, Issue:3 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Humans; Respiratory Tract Infections	2023

Other Studies

6 other study(ies) available for amikacin and Bronchiectasis

Article	Year
Nebulized Antibiotics in Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis: Shifting the Goal Posts or a Post Too Far? Respiration; international review of thoracic diseases, 2019, Volume: 97, Issue:6 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Fibrosis; Goals; Humans; Prospective Studies	2019
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014, Volume: 11, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2014
[Pleuropneumonia due to Mycobacterium chelonae]. Revue des maladies respiratoires, 2011, Volume: 28, Issue:3 Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drainage; Drug Therapy, Combination; Humans; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pleuropneumonia; Risk Factors; Treatment Outcome	2011
Repeated pulmonary infection by Nocardia asteroides complex in a patient with bronchiectasis. Respiration; international review of thoracic diseases, 1998, Volume: 65, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Bronchiectasis; Chronic Disease; Drug Therapy, Combination; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia asteroides; Nocardia Infections; Recurrence; Respiratory Tract Infections; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination	1998
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)]. The Japanese journal of antibiotics, 1978, Volume: 31, Issue:1 Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections	1978
The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Cystic Fibrosis; Humans; Kinetics; Macromolecular Substances; Mucus; Respiration Disorders; Sputum	1992